2016
Paediatric extracranial germ-cell tumours
Shaikh F, Murray MJ, Amatruda JF, Coleman N, Nicholson JC, Hale JP, Pashankar F, Stoneham SJ, Poynter JN, Olson TA, Billmire DF, Stark D, Rodriguez-Galindo C, Frazier AL. Paediatric extracranial germ-cell tumours. The Lancet Oncology 2016, 17: e149-e162. PMID: 27300675, DOI: 10.1016/s1470-2045(15)00545-8.Peer-Reviewed Original ResearchConceptsGerm cell tumorsPediatric extracranial germ cell tumorExtracranial germ cell tumorsPediatric germ cell tumorsSignificant long-term toxicityPoor-risk patientsLow-risk patientsPlatinum-resistant diseaseGroup of patientsHigh tumor markersEvidence-based careRisk stratification systemLong-term toxicityCooperative Research GroupExtragonadal tumorsRisk stratificationFuture trialsClinical behaviorPatient outcomesClinical dataAdult diseaseWide age rangeTumor markersTreatment approachesPatients
2015
Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration
Olson TA, Murray MJ, Rodriguez-Galindo C, Nicholson JC, Billmire DF, Krailo MD, Dang HM, Amatruda JF, Thornton CM, Arul GS, Stoneham SJ, Pashankar F, Stark D, Shaikh F, Gershenson DM, Covens A, Hurteau J, Stenning SP, Feldman DR, Grimison PS, Huddart RA, Sweeney C, Powles T, Lopes LF, dos Santos Agular S, Chinnaswamy G, Khaleel S, Abouelnaga S, Hale JP, Frazier AL. Pediatric and Adolescent Extracranial Germ Cell Tumors: The Road to Collaboration. Journal Of Clinical Oncology 2015, 33: 3018-3028. PMID: 26304902, PMCID: PMC4979195, DOI: 10.1200/jco.2014.60.5337.Peer-Reviewed Original ResearchMeSH KeywordsAdolescentAge of OnsetChildCooperative BehaviorDiffusion of InnovationFemaleHistory, 20th CenturyHistory, 21st CenturyHumansInterdisciplinary CommunicationInternational CooperationMaleMedical OncologyNeoplasms, Germ Cell and EmbryonalPediatricsSurvivorsTime FactorsTreatment OutcomeYoung AdultConceptsGerm cell tumorsPrimary tumor siteCell tumorsExtracranial malignant germ cell tumorsExtracranial germ cell tumorsTumor siteMalignant germ cell tumorsSignificant long-term morbidityDifferent risk stratificationLong-term morbidityPlatinum-based chemotherapyPediatric cancer patientsTreatment-related effectsDifferent cooperative groupsCisplatin dosingVariety of specialistsMedical oncologistsGynecologic oncologistsRisk stratificationTherapeutic dilemmaHistologic featuresPediatric oncologistsExcellent outcomesStaging systemCancer patients
2012
Children's Oncology Group's 2013 blueprint for research: Rare tumors
Rodriguez‐Galindo C, Krailo M, Frazier L, Chintagumpala M, Amatruda J, Katzenstein H, Malogolowkin M, Spector L, Pashankar F, Meyers R, Tomlinson G, Committee O. Children's Oncology Group's 2013 blueprint for research: Rare tumors. Pediatric Blood & Cancer 2012, 60: 1016-1021. PMID: 23255219, PMCID: PMC4304764, DOI: 10.1002/pbc.24428.Peer-Reviewed Original ResearchConceptsGerm cell tumorsCell tumorsRare cancersChildren's Oncology Group's 2013 blueprintInternational phase 3 clinical trialsPhase 3 clinical trialsEvidence-based definitionIntraocular retinoblastomaAdvanced carcinomaRisk stratificationInfrequent malignancyRare tumorClinical trialsClinical studiesLiver tumorsTumorsBiologic studiesChildrenCancerRetinoblastomaCarcinomaMalignancyHepatoblastomaYearsTrials